Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Breakthrough Genomics, |
RCV004596686 | SCV005088813 | likely pathogenic | PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome | 2022-04-21 | criteria provided, single submitter | clinical testing | This variant is predicted to be damaging by in-silico missense prediction tools (SIFT and Polyphen2). The variant seems to be novel, as it has not been previously reported in population or public databases or in the literature. In the family segregation analysis the varinat was found be de novo for the individual in our analysis. Based on ACMG guidelines [PS2 (do novo), PMS (absent from controls/low frequency in population), PP3 (multiple lines of computational evidences)], this variant was classified as 'likely pathogenic'. |